लोड हो रहा है...
Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer
Differentiated thyroid cancer accounts for >90% of cases of thyroid cancer, with most patients having an excellent prognosis. Distant metastases occur in 10%–15% of patients, decreasing the overall 10-year survival rate in this group to 40%. Radioactive iodine has been the mainstay of treatment f...
में बचाया:
मुख्य लेखकों: | , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
AlphaMed Press
2010
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227939/ https://ncbi.nlm.nih.gov/pubmed/20142332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0190 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|